publication . Other literature type . Thesis . 2017

Ghrelin receptor agonists as novel breast cancer therapeutics

  • Published: 13 Nov 2017
  • Publisher: Monash University
The human cell studies and the live mouse studies are intended to provide the information that is needed to apply therapies to treat breast cancer patients, based on our novel discoveries. We believe that des-acyl ghrelin-like compounds will be novel breast cancer therapeutics while avoiding well-documented serious side effects, including joint pain, osteoporosis or endometrial cancer. Our findings could therefore improve the quality of life of women treated for breast cancer, improve compliance and improve survival.
free text keywords: 60111 Signal Transduction, FOS: Biological sciences, 111201 Cancer Cell Biology, FOS: Clinical medicine, Cell Biology, Molecular Biology, Cancer Cell Biology, Signal Transduction, breast cancer, ghrelin, aromatase, des-acyl ghrelin, inflammation, GPCR, cAMP, obesity
Download fromView all 3 versions
Thesis . 2017
Provider: FigShare
Other literature type . 2017
Provider: Datacite
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue